Literature DB >> 26976558

Timing of delivery and pregnancy outcomes in women with gestational diabetes.

Maisa N Feghali1, Steve N Caritis2, Janet M Catov2, Christina M Scifres3.   

Abstract

BACKGROUND: Women with gestational diabetes mellitus (GDM) commonly undergo induction of labor (IOL) at term, but the risks and benefits of IOL are incompletely understood.
OBJECTIVE: We examined the relationship among gestational age, IOL, and the rate of cesarean delivery (CD) in women with GDM. STUDY
DESIGN: We identified 863 women with GDM who underwent either IOL or spontaneous labor ≥37 0/7 weeks. Demographic, cervical favorability, and outcome data were abstracted from the medical record. We compared the CD rate in women undergoing IOL at each week of gestation with expectant management to a later gestational age.
RESULTS: When compared to women who were expectantly managed, IOL at 37 weeks (adjusted odds ratio [aOR], 1.53; 95% confidence interval [CI], 0.76-3.06; P = .23), 38 weeks (aOR, 2.07; 95% CI, 0.89-4.80; P = .09), and 39 weeks (aOR, 0.79; 95% CI, 0.44-1.42; P = .43)) was associated with similar risk for CD as expectant management after adjustment for nulliparity, body mass index, baseline simplified Bishop score, and maternal age. CD rates were higher in nulliparous women, but did not differ significantly in those undergoing IOL or expectant management. In multiparous women, IOL was significantly associated with an increased risk for CD at 38 weeks (aOR, 7.47; 95% CI, 1.6-34.8; P = .01) and rates of CD (17.39% vs 2.2%, P = .001) were significantly higher in multiparous women with an unfavorable Bishop score induced <39 weeks. Neonatal morbidity was similar across gestational ages after adjustment for maternal body mass index and maternal glycemic control.
CONCLUSION: IOL results in similar risk for CD as expectant management between 37-40 weeks of gestation. Rates of CD differed based on cervical exam and parity. These findings suggest that gestational age alone does not significantly impact maternal and neonatal outcomes, but that decisions regarding delivery in women with GDM should take into account cervical exam and parity.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  gestational diabetes; induction of labor; timing of delivery

Mesh:

Year:  2016        PMID: 26976558      PMCID: PMC4967397          DOI: 10.1016/j.ajog.2016.03.006

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  29 in total

1.  Cesarean delivery after elective induction in nulliparous women: the physician effect.

Authors:  David A Luthy; Judith A Malmgren; Rosalee W Zingheim
Journal:  Am J Obstet Gynecol       Date:  2004-11       Impact factor: 8.661

2.  Delivery timing and cesarean delivery risk in women with mild gestational diabetes mellitus.

Authors:  Amelia L Sutton; Lisa Mele; Mark B Landon; Susan M Ramin; Michael W Varner; John M Thorp; Anthony Sciscione; Patrick Catalano; Margaret Harper; George Saade; Steve N Caritis; Yoram Sorokin; William A Grobman
Journal:  Am J Obstet Gynecol       Date:  2014-03-04       Impact factor: 8.661

3.  Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.

Authors:  Caroline A Crowther; Janet E Hiller; John R Moss; Andrew J McPhee; William S Jeffries; Jeffrey S Robinson
Journal:  N Engl J Med       Date:  2005-06-12       Impact factor: 91.245

4.  Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial.

Authors:  Michel Boulvain; Marie-Victoire Senat; Franck Perrotin; Norbert Winer; Gael Beucher; Damien Subtil; Florence Bretelle; Elie Azria; Dominique Hejaiej; Françoise Vendittelli; Marianne Capelle; Bruno Langer; Richard Matis; Laure Connan; Philippe Gillard; Christine Kirkpatrick; Gilles Ceysens; Gilles Faron; Olivier Irion; Patrick Rozenberg
Journal:  Lancet       Date:  2015-04-08       Impact factor: 79.321

5.  Induction of labor at 38 to 39 weeks of gestation reduces the incidence of shoulder dystocia in gestational diabetic patients class A2.

Authors:  S Lurie; V Insler; Z J Hagay
Journal:  Am J Perinatol       Date:  1996-07       Impact factor: 1.862

6.  Gestational diabetes mellitus--implications of different treatment protocols.

Authors:  Yoav Peled; Tamar Perri; Rony Chen; Joseph Pardo; Jacob Bar; Moshe Hod
Journal:  J Pediatr Endocrinol Metab       Date:  2004-06       Impact factor: 1.634

7.  What is the optimal gestational age for women with gestational diabetes type A1 to deliver?

Authors:  Brenda Niu; Vanessa R Lee; Yvonne W Cheng; Antonio E Frias; James M Nicholson; Aaron B Caughey
Journal:  Am J Obstet Gynecol       Date:  2014-06-06       Impact factor: 8.661

8.  Elective induction of labor at term compared with expectant management: maternal and neonatal outcomes.

Authors:  Blair G Darney; Jonathan M Snowden; Yvonne W Cheng; Lorie Jacob; James M Nicholson; Anjali Kaimal; Sascha Dublin; Darios Getahun; Aaron B Caughey
Journal:  Obstet Gynecol       Date:  2013-10       Impact factor: 7.661

Review 9.  Timing of indicated late-preterm and early-term birth.

Authors:  Catherine Y Spong; Brian M Mercer; Mary D'Alton; Sarah Kilpatrick; Sean Blackwell; George Saade
Journal:  Obstet Gynecol       Date:  2011-08       Impact factor: 7.623

10.  Using a simplified Bishop score to predict vaginal delivery.

Authors:  S Katherine Laughon; Jun Zhang; James Troendle; Liping Sun; Uma M Reddy
Journal:  Obstet Gynecol       Date:  2011-04       Impact factor: 7.623

View more
  2 in total

1.  A systematic scoping review of clinical indications for induction of labour.

Authors:  Dominiek Coates; Angela Makris; Christine Catling; Amanda Henry; Vanessa Scarf; Nicole Watts; Deborah Fox; Purshaiyna Thirukumar; Vincent Wong; Hamish Russell; Caroline Homer
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

2.  Metabolic profiling of pre-gestational and gestational diabetes mellitus identifies novel predictors of pre-term delivery.

Authors:  Ilhame Diboun; Manjunath Ramanjaneya; Yasser Majeed; Lina Ahmed; Mohammed Bashir; Alexandra E Butler; Abdul Badi Abou-Samra; Stephen L Atkin; Nayef A Mazloum; Mohamed A Elrayess
Journal:  J Transl Med       Date:  2020-09-24       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.